Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

EIHSX:US

13.74 USD 0.17 1.25%

As of 20:00:00 ET on 03/30/2015.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (EIHSX)

Year To Date: +10.72% 3-Month: +10.18% 3-Year: +29.16% 52-Week Range: 9.70 - 14.02
1-Month: +4.25% 1-Year: +34.49% 5-Year: +18.78% Beta vs SPX: 0.90

Mutual Fund Chart for EIHSX

No chart data available.
  • EIHSX:US 13.74
  • 1M
  • 1Y
Interactive EIHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for EIHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 10-01-2009 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for EIHSX

NAV (on 2015-03-30) 13.74
Assets (M) (on 2015-02-27) 1,715.20
Fund Leveraged N
Minimum Investment 250,000.00
Minimum Subsequent Investment 0.00

Dividends for EIHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-16) 0.56
Dividend Yield (ttm) 14.68

Fees & Expenses for EIHSX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.02
Redemption Fee 1.00
12b1 Fee 0.00
Expense Ratio 1.21

Top Fund Holdings for EIHSX

Filing Date: 01/31/2015
Name Position Value % of Total
HCA Holdings Inc 942,000 66,693,600 4.086%
Bristol-Myers Squibb Co 1,080,000 65,091,600 3.988%
Biogen Inc 156,000 60,708,960 3.719%
Amgen Inc 392,000 59,685,920 3.657%
AbbVie Inc 970,000 58,539,500 3.586%
Gilead Sciences Inc 548,200 57,467,806 3.521%
Regeneron Pharmaceuticals Inc 126,000 52,499,160 3.216%
Actavis plc 195,300 52,055,262 3.189%
Ono Pharmaceutical Co Ltd 489,700 51,538,027 3.157%
Incyte Corp 643,800 51,317,298 3.144%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil